Revenue Analysis - EW
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
EW Corporation
Annual
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Transcatheter Heart Valves
0.0% of total revenue
$1.2B
Transcatheter Mitral And Tricuspid Therapies
0.0% of total revenue
$175.1M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Surgical Heart Valve Therapy | Transcatheter Heart Valves | Transcatheter Mitral And Tricuspid Therapies |
|---|---|---|---|
| 3/31/2026 | $0 | $1.2B | $175.1M |
| 12/31/2025 | $253.6M | $1.2B | $155.7M |
| 9/30/2025 | $258.0M | $1.1B | $145.2M |
| 6/30/2025 | $266.8M | $1.1B | $134.5M |
| 3/31/2025 | $250.9M | $1.0B | $115.2M |
| 12/31/2024 | $210.9M | $1.0B | $105.1M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Growing Segments
Transcatheter Mitral And Tricuspid Therapies+12.5%
Earnings Reports
Want to see how EW's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports